Letter to the Editor
Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes?

https://doi.org/10.1016/j.jhin.2005.03.011Get rights and content

References (8)

  • G. Aubert et al.

    Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit

    J Hosp Infect

    (2005)
  • P. Charbonneau et al.

    Impact of a 12-month fluoroquinolone (FQ) restriction on MRSA incidence in a French university hospital [abstract K-1743]

    (2003)
  • D.L. Monnet et al.

    Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996—2000

    Emerg Infect Dis

    (2004)
  • J.M. Keegan et al.

    Development of a strategy for decreasing multi-drug resistant bacteria with implementation of a program emphasizing appropriate antibiotic utilization and strict infection control measures in Western South Dakota

    S D Med J

    (2002)
There are more references available in the full text version of this article.

Cited by (8)

  • MRSA bacteraemia

    2007, International Journal of Antimicrobial Agents
    Citation Excerpt :

    Another possible explanation for the increased risk of both serious infections, such as SAB, and death after acquisition of MRSA as opposed to MSSA concerns prior antibiotic use as a predisposition. While a recent Cochrane review provided no robust evidence that antibiotic stewardship interventions influence MRSA rates, there are now approaching a dozen papers [24] that provide plausible and consistent evidence that reduction of third-generation cephalosporin (3GC) and 4-fluoroquinolone (4FQ) prescribing can lead to reduced MRSA rates. Some of the more recent studies are of interrupted time series methodology which will be considered by Cochrane in its update.

  • Antibiotic resistance: Location, location, location

    2007, Clinical Microbiology and Infection
    Citation Excerpt :

    Even discounting such factors, there is still variation in MRSA bacteraemia rates when ostensibly similar acute-care general hospitals in England are compared with each other. Such variation must partly reflect relative attention to infection control and antibiotic usage patterns [24], although the roles of quinolones and cephalosporins in MRSA selection remain controversial [25,26], and a recent study found little correlation between visual cleanliness and the incidence of MRSA bacteraemias [27]. The other critical factor is case-mix: MRSA bacteraemias are rare among maternity and psychiatric patients and in infants, so that large units handling these patients will ‘dilute’ a hospital's rate, calculated as cases per 1000 bed-days across the whole site [21].

  • Look to Norway - men hvor lenge?

    2010, Tidsskrift for den Norske Laegeforening
View all citing articles on Scopus
View full text